SLXP

Salix Pharmaceuticals, Ltd. Press Releases

$157.62
*  
0.18
0.11%
Get SLXP Alerts
*Delayed - data as of Mar. 6, 2015 9:54 ET  -  Find a broker to begin trading SLXP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SLXP Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Salix Pharmaceuticals Reports 4Q2014 and FY2014 Results
3/2/2015 4:01:00 PM - Business Wire
































Napo Files Brief on Appeal In Dispute With Salix
2/3/2015 10:39:00 AM - PR Newswire






Salix Provides Update on Audit Committee Review
1/28/2015 4:45:00 PM - Business Wire
▲23.25 % Price Change since this news event. The Volume Ratio is 1.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


The Shuman Law Firm Investigates Salix Pharmaceuticals Ltd.
1/9/2015 8:00:00 PM - Business Wire
▲33.47 % Price Change since this news event. The Volume Ratio is 0.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pharming and Salix Announce First Patient Treated in Clinical Study of Ruconest® for Prophylaxis of Hereditary Angioedema
1/8/2015 10:33:00 AM - Business Wire
▲30.19 % Price Change since this news event. The Volume Ratio is 1.02.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Carolyn Logan to Retire as Chief Executive Officer of Salix Pharmaceuticals
1/5/2015 4:01:00 PM - Business Wire
▲39.68 % Price Change since this news event. The Volume Ratio is 6.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Salix Pharmaceuticals, Ltd. Of Upcoming Deadline
12/24/2014 5:04:00 PM - Business Wire
▲37.16 % Price Change since this news event. The Volume Ratio is 0.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day